Cavendish Financial plc (LON:CAV – Get Free Report) insider Mark Astaire purchased 4,103 shares of the company’s stock in a transaction that occurred on Tuesday, November 12th. The shares were purchased at an average cost of GBX 11 ($0.14) per share, for a total transaction of £451.33 ($568.78).
Cavendish Financial Stock Performance
CAV stock opened at GBX 10.89 ($0.14) on Friday. The stock’s 50 day simple moving average is GBX 10.35 and its 200 day simple moving average is GBX 11.78. The company has a market cap of £36.18 million, a P/E ratio of -1,050.00 and a beta of 1.23. Cavendish Financial plc has a fifty-two week low of GBX 6.80 ($0.09) and a fifty-two week high of GBX 15 ($0.19).
Cavendish Financial Increases Dividend
The business also recently disclosed a dividend, which will be paid on Wednesday, December 11th. Shareholders of record on Thursday, November 21st will be issued a dividend of GBX 0.30 ($0.00) per share. This is a positive change from Cavendish Financial’s previous dividend of $0.25. This represents a yield of 2.73%. The ex-dividend date is Thursday, November 21st. Cavendish Financial’s payout ratio is currently -20,000.00%.
About Cavendish Financial
Cavendish Financial plc provides various financial services to growth companies in the United Kingdom. The company offers equities research, distribution and execution, and analytics services. It provides investment banking services, such as strategic advisory and capital raising services comprising public market fund raisings, including placings, rights issues, and open offers; IPOs; sell-side or buy-side private M&A; public company M&A; debt arrangement and advice; private capital fund raisings; and general advice on strategic options, as well as acts as a corporate broker/NOMAD on a retained basis.
Featured Stories
- Five stocks we like better than Cavendish Financial
- Investing In Preferred Stock vs. Common Stock
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Top-Performing Non-Leveraged ETFs This Year
- Top Biotech Stocks: Exploring Innovation Opportunities
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Cavendish Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavendish Financial and related companies with MarketBeat.com's FREE daily email newsletter.